Nightfood
Nightfood Holdings Inc. (OTCQB: NGTF), operating under the TechForce Robotics brand, is engineering a solution to this problem with a proprietary Robotic Connective Network and…
Company lists
Life science tech, oncology, genomics, research tools, startups and more: the companies building life sciences in New York, with their founders, funding, team size and business models.
Funding, M&A, contract wins and launches involving 1,544 life sciences companies in New York, last 24 months: 102 M&A deals · 100 funding rounds · 31 Contracts · 8 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jul 2026.
Nightfood Holdings Inc. (OTCQB: NGTF), operating under the TechForce Robotics brand, is engineering a solution to this problem with a proprietary Robotic Connective Network and…
Everest Medicines announced that it has entered into a commercialization license agreement with Beijing Mabworks Biotech Co., Ltd. under which the Company has obtained exclusive rights…
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced definitive agreements with accredited investors for a registered direct offering expected to generate approximately $16.6 million in…
Waypoint Bio, an innovative biotechnology firm leveraging artificial intelligence to pioneer advanced CAR T-cell therapies for challenging solid tumors, has successfully closed a $20…
Dragos has acquired Phosphorus, broadening its reach across connected devices in operational environments.
Kaos Capital Ltd. ('Kaos Capital' or 'we'), a Miami-based hedge fund focused on activist investing, today announced that it has acquired 4.9% of the issued and outstanding common stock…
Dragos enhances its xOT cybersecurity platform with the acquisition of Phosphorus, bolstering defense for critical infrastructure's connected devices.
FONAR Corporation (NASDAQ: FONR) has entered into a merger agreement under which it would be taken private by an entity (the "Parent") controlled by its CEO and Chairman, Timothy Damadian.
Candid is choosing the M&A route instead, opting to accept a $2 billion buyout offer that gives UCB the biotech’s pipeline of T cell engagers for immune disorders.
Sowell Launches 'Family Office Lite,' Advisor Partnership Program Merchant has agrees to provide funding for future M&As to the RIA led by Bill Sowell.
Rocket Pharmaceuticals announced this week the sale of its rare pediatric disease priority review voucher (PRV) for $180 million.
Lucid Diagnostics on Thursday announced that it had priced an underwritten registered direct offering of 18,000,000 common shares at a purchase price of $1.00 per share for total…
Nightfood Holdings Inc., operating through its TechForce Robotics subsidiary, has executed a strategic supply agreement with NUWA Robotics Corp. and Foxconn, signaling its transition…
Nightfood Holdings Inc., operating through its TechForce Robotics subsidiary, has executed a strategic supply agreement with NUWA Robotics Corp. and Foxconn, signaling its transition…
Everest Medicines’ wholly owned subsidiary EverSea Medicines (Singapore) has signed a share purchase agreement to conditionally acquire Hasten Biopharmaceuticals, a subsidiary of Hasten…
Horizon Technology Finance Corporation announced it has provided a $40 million loan facility to Hyperfine, Inc., with an initial $15 million funded at closing and up to $25 million…
Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing first-in-class treatments for stress-related neuropsychiatric disorders, today announced…
Deals included a $2.7 billion financing for cloud services platform Dropbox and $570 million for Axsome Therapeutics.
In recent days, his firm acquired a significant amount of shares from Recursion Pharmaceuticals, a biotechnology company that uses artificial intelligence to accelerate
One of the standout healthtech deals was Esper Bionics, which secured $5 million in a round led by YZR Capital.
Pfizer’s fight with Novo Nordisk to buy obesity drug start-up Metsera
Epicured, a food-is-medicine meal delivery company originally focused on digestive health, has acquired Chiyo, a women’s nutrition company offering stage-specific meal programs spanning…
ILiAD Biotechnologies , a biotech based in FL, USA raised a $115 M Series B funding round.
Immunic, Inc. (Nasdaq: IMUX), a late‑stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced the…
Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has raised £2,500,000 from a consortium of private investors through a direct subscription for 313,333 new…
Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), announces that the 'Exclusive Distribution Agreement' dated July 1, 2025, between Evolutionary Biologics (a wholly owned…
In fact, ... One example is healthtech company Thorne, which recently unveiled Taia, its AI-powered wellness advisor.
LB Pharmaceuticals Inc announced that it has entered into a securities purchase agreement to sell 3,306,571 shares of its common stock and pre-funded warrants to purchase up to 1,417,107…
Daxor Corporation (NasdaqCM: DXR) ("Daxor" or the "Company") announced today that it has entered into a definitive agreement with fundamental investors for the purchase and sale of an…
Lucid Diagnostics awarded U.S. Dept of Veterans Affairs contract for EsoGuard
Few life sciences companies in New York publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 1,116 active companies.

Provider of a digital platform for weight loss management and behavior change
Fitness & wellness techUS$623.85m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Mobile platforms for group-based wellness and health behavior support
CPC G16H20/60, H04L67/22, G16H40/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of AI-powered drug discovery platform for various diseases
Life sciences techUS$608.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

AI and cloud-based platforms provide data-driven insights to healthcare providers
Healthcare itUS$514.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Discovering novel therapeutics for neurological and metabolic diseases
Life sciences platforms and toolsUS$479.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: NK3 receptor modulators for treating neurological and metabolic disorders
CPC C07D471/04, A61P1/00, C07D498/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

AI-enabled drug discovery and development platform for novel therapeutics
Life sciences techUS$447.94m across 10 disclosed equity rounds
Darker bars = larger rounds
Focus: AI-driven drug discovery: predictive bioactivity, phenomics, and active‑learning compound design
CPC A61P35/00, G01N33/5026, G16C20/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of implantable bioelectronics for the treatment of neurological conditions
NeurologyUS$325.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of medical affair services for biopharma and medical device industry
Life sciences techUS$320.86m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs for the treatment of cancer
ImmunologyUS$313.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of closed-system transfer devices for handling drugs
Hospital equipmentEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of next-generation of immunomodulatory therapeutics
GenomicsUS$295.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for cancer treatment
OncologyFocus: Design and synthesis of heterocyclic small‑molecule cancer drugs targeting nuclear hormone receptors.
CPC C07D471/04, C07D487/04, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of pipetting robot for lab automation
Life sciences platforms and toolsUS$260.68m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of clinical research healthcare services
Life sciences techFocus: Secure digital credential issuance and verification for government, construction, and IoT devices.
CPC H04L63/123, B62M6/75, G06F21/45Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases
NeurologyUS$185.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of rare neurological disorders
GenomicsUS$183.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered protein therapeutics for T‑reg activation and optimized GALC enzyme replacement.
CPC C07K16/2866, C07K14/475Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developed of brain-computer interface tool for medical treatment and drug development
Brain computer interfaceUS$182.65m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of an automated platform for patients and clinics to manage frozen eggs and embryos
Women healthUS$176.91m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of immunity-inducing vaccine for the prevention and treatment of pertussis
Infectious diseasesUS$166.17m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Lyophilized live bacterial vaccine production and neuroprotective therapeutic formulations.
CPC A61K39/099, A61M3/0283, A61P25/28Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of nanoparticle immunomodulatory drugs for treating multiple diseases
GenomicsUS$155.09m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Tolerogenic nanocarrier delivery systems for immune‑tolerant therapeutic protein formulations
CPC A61K39/385, A61K31/436, A61K38/38Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of drugs for neuropsychiatric conditions
NeurologyUS$151.55m across 10 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of dental aligners
Dental disordersUS$147.78m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Automated deployment and management of cloud infrastructure services
CPC G06Q10/0633, H04L41/145Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of medications to treat ophthalmic diseases
OphthalmologyUS$142.20m across 9 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of an AI models for protein design
Life sciences techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer small molecule-based therapies for cancers
ImmunologyUS$133.26m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Targeted protein degradation and small‑molecule therapeutics for disease treatment
CPC C07D495/04, C07D403/04, C07D401/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule based therapeutics for schizophrenia
NeurologyUS$130.09m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule immunomodulators targeting CXCR4/Btk, IL-6, and complement pathways
CPC A61K38/12, A61K31/4709, A61K38/08Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of solid and liquid cancers
OncologyUS$128.15m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Cancer immunotherapy: GCN2 modulators, beta‑glucan/CD40 agonists, and novel crystalline drugs
CPC A61K31/716, A61K31/4985, C07D487/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of orphan indications
GenomicsUS$127.74m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of fertility and menopause
Women healthUS$127.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: In vitro ovarian/uterine organoid and gamete engineering for reproductive and stem‑cell applications
CPC C12N5/0609, G01N33/5044, A61L27/38Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule therapeutics for cancer and genetic diseases
GenomicsUS$124.40m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07D401/14, C07F9/65583, C12Q1/6886Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of hemostatic products for wound care
Wound careUS$118.35m across 8 disclosed equity rounds
Darker bars = larger roundsFocus: Surgical hemostatic adhesive polymers and in‑situ cross‑linkable wound‑sealant scaffolds.
CPC A61L26/0052, A61L15/225, A61M5/30Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for cancer treatment
GenomicsUS$117.27m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of smart baby monitoring systems with sleep and breathing analysis
Sleep medicineUS$116.60m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Proton Beam Therapy. Treatment for different types of Cancerous and non-cancerous tumors through Proton Therapy.
OncologyUS$115.61m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics to treat neurological diseases
NeurologyUS$114.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Manufacturer of drugs for treating inflammation
ImmunologyUS$108.52m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of workforce healthcare solutions
Disease self managementUS$107.87m across 7 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for rare neurological diseases
Rare diseasesUS$105.92m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K31/437, A61K31/196, C12N15/113Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Brand of nutrition supplements
Food & beverage productsUS$104.80m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Portable solar-powered smart speakers and low-floor vehicle suspension technologies
CPC B60G7/02, H04R1/2857, H04R1/403Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapies targeting neural circuits for immune and inflammatory diseases
ImmunologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a minimally invasive eye surgery technology
OphthalmologyUS$97.78m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Glaucoma treatment via biologic intraocular stents and aqueous drainage devices
CPC A61F9/00781, A61L27/3604, A61F9/0017Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of precision medicine for the treatment of cancer
ImmunotherapyUS$97.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Therapeutic anti‑ERBB3 (HER3) monoclonal antibodies for NRG1‑fusion driven cancers
CPC C07K16/32, A61K39/39558Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for the treatment of Autism and other neurological diseases
NeurologyUS$95.96m across 13 disclosed equity rounds
Darker bars = larger roundsFocus: Neuropsychiatric disorder therapeutics and addiction treatment formulations
CPC A61K38/54, A61K38/4826, A61K38/465Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of CAR-T cell therapy for brain cancer and acute myeloid leukemia treatment
Cell therapyUS$95.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Provider of artificial intelligence-based solutions for accelerating drug discovery and development processes
Life sciences techUS$91.45m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Small-molecule kinase degraders and inhibitors for cancer therapy, plus docking prediction tools
CPC C07D401/14, C07D487/04, C07D405/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for cancer
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of a platform for programmable protein interaction-based drug discovery
Life sciences techEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of small molecule therapeutics for cancer treatment
OncologyEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

AI-based drug discovery tool for researchers
Life sciences techUS$82.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Optimized photovoltaic module assemblies with parameter matching and UV filtering
CPC H10F19/40, B25J9/041, H10K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Developer of therapeutics for invasive fungal infections
Infectious diseasesEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Online platform offering artificial intelligence-powered personalized grocery service
Online groceryUS$78.31m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: AI-powered grocery recommendation, recipe personalization, and automated packaging for perishable foods
CPC G06Q10/087, G06Q10/0833, G06Q30/0631Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in New York on RadarFind top life sciences companies in New York for drug discovery, oncology, genomics, and research tools. Explore life sciences startups in New York and companies hiring in life sciences.
Technology companies supporting life science research and development.

Provider of AI-powered drug discovery platform for various diseases
Life sciences tech
Developer of next-generation of immunomodulatory therapeutics
Genomics
Provider of clinical research healthcare services
Life sciences tech
Provider of an AI models for protein design
Life sciences tech
Provider of artificial intelligence-based solutions for accelerating drug discovery and development processes
Life sciences techCompanies developing diagnostics and therapies for cancer care.

Developer of drugs for the treatment of cancer
Immunology
Developer of therapeutics for cancer treatment
Oncology
Developer of therapeutics for the treatment of rare neurological disorders
Genomics
Developer of nanoparticle immunomodulatory drugs for treating multiple diseases
Genomics
Developer small molecule-based therapies for cancers
ImmunologyCompanies working with genomics, sequencing, and genetic health applications.

Discovering novel therapeutics for neurological and metabolic diseases
Life sciences platforms and tools
Developer of next-generation of immunomodulatory therapeutics
Genomics
Developer of therapeutics for the treatment of rare neurological disorders
Genomics
Developer of nanoparticle immunomodulatory drugs for treating multiple diseases
Genomics
Developer of therapeutics for the treatment of orphan indications
GenomicsProviders of lab platforms, instruments, and research tools.

Discovering novel therapeutics for neurological and metabolic diseases
Life sciences platforms and tools
Developer of pipetting robot for lab automation
Life sciences platforms and tools
Provider of instruments for automated assays
Life sciences platforms and tools
Provider of bioactive peptides, peptide synthesis, and GMP manufacturing services
Biopharma outsourcing
Developer of live-attenuated viral vaccines using proprietary SAVE technology
GenomicsRecently founded life sciences companies in New York.

Developed of brain-computer interface tool for medical treatment and drug development
Brain computer interface
Provider of an AI models for protein design
Life sciences tech
Developer of therapeutics to treat neurological diseases
Neurology
Developer of therapies targeting neural circuits for immune and inflammatory diseases
Immunology
AI-based drug discovery tool for researchers
Life sciences techLife sciences companies in New York with hiring activity.

Provider of AI-powered drug discovery platform for various diseases
Life sciences tech
AI and cloud-based platforms provide data-driven insights to healthcare providers
Healthcare it
AI-enabled drug discovery and development platform for novel therapeutics
Life sciences tech
Developer of implantable bioelectronics for the treatment of neurological conditions
Neurology
Developer of therapeutics for cancer treatment
OncologyListed life sciences companies based in New York.

AI-enabled drug discovery and development platform for novel therapeutics
Life sciences tech
Developer of drugs for the treatment of cancer
Immunology
Developer of therapeutics for cancer treatment
Oncology
Developer of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases
Neurology
Developer of therapeutics for the treatment of rare neurological disorders
GenomicsThe most-installed Android apps published by life sciences companies headquartered in New York — 23.1M installs between them. 17 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how New York compares. Debt, IPO and grant rounds are excluded.
US$13.54bn
US$37.38bn
5,603 rounds in the United States
last 24 months
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
Equity rounds over the last five years, 1,544 life sciences companies in New York among 27,407 in the United States.
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesThe financials above are one chapter. The full life sciences landscape of New York maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
323 life sciences companies in New York have recorded equity funding, US$13.58bn in total. Totals and round dates describe the historical record; they are not current valuations.
Largest recorded equity totals, with the latest recorded round.
Fitness & wellness techProvider of a digital platform for weight loss management and behavior change
Life sciences techProvider of AI-powered drug discovery platform for various diseases
Healthcare itAI and cloud-based platforms provide data-driven insights to healthcare providers
Life sciences platforms and toolsDiscovering novel therapeutics for neurological and metabolic diseases
Life sciences techAI-enabled drug discovery and development platform for novel therapeutics

NeurologyDeveloper of implantable bioelectronics for the treatment of neurological conditions
Life sciences techProvider of medical affair services for biopharma and medical device industry
ImmunologyDeveloper of drugs for the treatment of cancer
Hospital equipmentDeveloper of closed-system transfer devices for handling drugs
GenomicsDeveloper of next-generation of immunomodulatory therapeutics
OncologyDeveloper of therapeutics for cancer treatment
Life sciences platforms and toolsDeveloper of pipetting robot for lab automation
Life sciences techProvider of clinical research healthcare services
Founders
Details not available
NeurologyDeveloper of gene therapy for the treatment of CLN2 Batten and Alzheimer's diseases
GenomicsDeveloper of therapeutics for the treatment of rare neurological disorders
Brain computer interfaceDeveloped of brain-computer interface tool for medical treatment and drug development
US$623.85m across 6 disclosed equity rounds
Darker bars = larger roundsFocus: Mobile platforms for group-based wellness and health behavior support
CPC G16H20/60, H04L67/22, G16H40/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$608.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$514.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$479.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: NK3 receptor modulators for treating neurological and metabolic disorders
CPC C07D471/04, A61P1/00, C07D498/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$447.94m across 10 disclosed equity rounds
Darker bars = larger rounds
Focus: AI-driven drug discovery: predictive bioactivity, phenomics, and active‑learning compound design
CPC A61P35/00, G01N33/5026, G16C20/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$325.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$320.86m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$313.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$295.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Design and synthesis of heterocyclic small‑molecule cancer drugs targeting nuclear hormone receptors.
CPC C07D471/04, C07D487/04, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$260.68m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Secure digital credential issuance and verification for government, construction, and IoT devices.
CPC H04L63/123, B62M6/75, G06F21/45Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$185.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$183.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered protein therapeutics for T‑reg activation and optimized GALC enzyme replacement.
CPC C07K16/2866, C07K14/475Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$182.65m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Meet the people behind life sciences companies in New York. 759 of 1,116 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
OncologyDeveloping novel immunotherapy agents for cancer and inflammatory diseases
Life sciences platforms and toolsBulk producer of Industrial enzymes
Founders
Details not available
Imaging diagnosticsDevelops Upright Multi-Position MRI
GastroenterologySupplements and reviews for HGH, male enhancement, and legal steroids
Life sciences techAI-based drug discovery tool for researchers
OrthopedicsCustom foot and ankle orthotic devices
OncologyProton Beam Therapy. Treatment for different types of Cancerous and non-cancerous tumors through Proton Therapy.
Wearable technologyDeveloper of AI and cloud-based device for cardiac health monitoring and activity tracking
OncologyDeveloper of medical devices and biomarkers to detect various diseases
NeurologyProvider of therapeutic solution for patients with neurological and psychiatric illnesses
Diversified pharmaceuticalsDeveloper of small molecules and gene delivery vectors
Life sciences techDeveloper of diagnostic tests for central nervous system and gastrointestinal disorders
US$54.93m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$17.43m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$82.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Optimized photovoltaic module assemblies with parameter matching and UV filtering
CPC H10F19/40, B25J9/041, H10K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$115.61m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$47.60m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61B18/1492, A61M39/02, A61M25/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$47.65m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Molecular exposomics platforms and bio-surface topographic imaging for health monitoring
CPC G01B11/24, G01N33/6848, G16H10/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in New York with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
GenomicsProvider of next-generation gene-editing therapies

Dental disordersDeveloper of dental aligners
Online groceryInternet first restaurant offering plant-based ready-to-eat meals
Life sciences techProvider of AI-based clinical trial management tool
GenomicsDeveloper of therapeutics for the treatment of orphan indications
Diversified pharmaceuticalsDiscovery, development and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases
GenomicsAI-driven biotechnology company that focuses on the discovery and development of novel RNA splicing therapeutics
Food techInternet first restaurant delivering plant-based smoothies and meals
Women healthDeveloper of therapeutics for the treatment of fertility and menopause
OrthopedicsDeveloper of patient‑specific bone and cartilage grafts
GenomicsCloud platform for personal genomics
Women healthPioneering ovarian health therapeutics for women's unique biological needs
US$3.75m across 2 disclosed equity rounds
Darker bars = larger rounds
Focus: Lipid nanoparticle delivery systems for tissue-specific CRISPR gene editing therapies.
CPC C12N15/11, C07D317/28, C12N15/1138Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$147.78m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Automated deployment and management of cloud infrastructure services
CPC G06Q10/0633, H04L41/145Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$23.59m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$14.13m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$127.74m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Peptide immunogen design for veterinary vaccines and human therapeutic peptide drugs
CPC C07K14/4711, A61K39/0006, A61K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$46.78m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Cancer immunotherapy via neoantigen discovery and splicing‑based biomarker platforms
CPC C12N15/113, G16B20/00, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.26m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$127.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: In vitro ovarian/uterine organoid and gamete engineering for reproductive and stem‑cell applications
CPC C12N5/0609, G01N33/5044, A61L27/38Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$48.63m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Regenerative orthopedic biomaterials: injectable off‑the‑shelf cartilage/tendon/ligament scaffolds and decellularized bone matrice
CPC C12N5/0068, A61L27/46, C12M21/08Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.82m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Integrated low‑pass whole‑genome and targeted DNA sequencing for comprehensive genomic analysis
CPC C12Q1/6874Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$24.89m across 7 disclosed equity rounds
Darker bars = larger roundsFocus: FSH receptor modulators and peripheral melatonin agonist formulations for reproductive health
CPC C12Q1/6883, G16B40/00, G16H10/60Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences companies in New York founded in the last four years, newest first.
NeurologyDeveloper of therapeutics for neuropsychiatric disorders like treatment-resistant schizophrenia
Founders
Details not available
Dental disordersManufacturer of professional-grade teeth whitening agents for dentists and distributors
Founders
Details not available
Online retailer of supplements formulated for managing polycystic ovary syndrome
Founders
Details not available
Life sciences techAI-driven platform focused on drug discovery through biological simulation
ImmunologyDeveloper of gene therapy solutions designed for precision and safety
Life sciences techProvider of a platform for drug discovery for the treatment of cancer and rare diseases
Developer of therapies targeting autoimmune diseases using T-cell engager technology
Founders
Details not available
NeurologyDeveloper of therapies intended to transform mental health treatment options
Life sciences platforms and toolsAI-driven platform revolutionizing drug discovery with generative molecule design
Founders
Details not available
Life sciences techProvider of a platform for clinical trial data analysis
Founders
Details not available
Life sciences techAI based phenotypic drug discovery platform
Founders
Details not available
Provider of regulatory intelligence platform for pharmaceutical and medical device companies
Founders
Details not available
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$50.60m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
Life sciences techAI-enabled drug discovery and development platform for novel therapeutics

ImmunotherapyDeveloper of treatments for B-cell malignancies and autoimmune diseases
NeurologyTherapeutics for addiction treatment
Infectious diseasesDeveloping novel antivirals to treat serious viral diseases

ImmunotherapyDeveloper of immunotherapeutics to treat cancer
GenomicsDeveloper of botanical-DNA based security and authentication solutions
NeurologyDeveloper of therapeutic solutions for the management of CNS disorders
Disease self managementDeveloper of fingerprint drug testing and sweat drug monitoring solutions
NeurologyDeveloper of next-generation medicines for CNS and immunological disorders
Infectious diseasesDeveloper of anti-infective therapeutics for bio-warfare threats
OncologySpeciality Pharmaceutical and medical device company focused on oncology
Nutraceuticals techManufacturer of nutraceutical ingredients for human and animal nutrition products
US$447.94m across 10 disclosed equity rounds
Darker bars = larger rounds
Focus: AI-driven drug discovery: predictive bioactivity, phenomics, and active‑learning compound design
CPC A61P35/00, G01N33/5026, G16C20/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in chemistry & materials
CPC C07H19/16, A61K31/5377, C07D487/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Focus: Antiviral heterocyclic small molecules and crystalline forms for herpes virus treatment
CPC C07D417/12, C07D403/08, C07D281/16Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$8.70m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in health & consumer products
CPC A61K31/5415, A61K31/137, A61K9/2009Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$4.45m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Antiviral small‑molecule synthesis and oral/IV formulation of Tecovirimat.
CPC C07D471/04, C07D209/56, A61K31/403Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61K38/1709, C07C215/40, C11C3/003Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The most common specialisations among life sciences companies in New York. Open a company to see what it sells, who runs it and how far it has come.
164 life sciences companies in New York work in life sciences tech. Shown: the best-documented.
Life sciences techAI-enabled drug discovery and development platform for novel therapeutics

Life sciences techProvider of medical affair services for biopharma and medical device industry
Healthcare itAI and cloud-based platforms provide data-driven insights to healthcare providers
Life sciences techElectronic Data Capture (EDC), eCRF, ePRO application for online data collection for medical research
Life sciences techAI-based drug discovery tool for researchers
GenomicsDeveloper of next-generation of immunomodulatory therapeutics
Life sciences techProvider of an AI based practice management software for clinic trials and clinics
Life sciences techCloud and AI-led analytics platform for drug discovery and development
Life sciences techDigital remote health monitoring tool for providers
Life sciences techProvider of AI-based clinical trial management tool
Life sciences techProvider of clinical research healthcare services
Founders
Details not available
Life sciences techResearch site network platform focuses on patient identification, enrollment, recruitment & retention
US$447.94m across 10 disclosed equity rounds
Darker bars = larger rounds
Focus: AI-driven drug discovery: predictive bioactivity, phenomics, and active‑learning compound design
CPC A61P35/00, G01N33/5026, G16C20/40Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$320.86m across 5 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$514.00m across 4 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$63.25m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$82.00m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Optimized photovoltaic module assemblies with parameter matching and UV filtering
CPC H10F19/40, B25J9/041, H10K39/12Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$295.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Clinical data integration and interactive health informatics platforms
CPC G16H70/40, G16H10/20Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$70.65m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$14.13m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Secure digital credential issuance and verification for government, construction, and IoT devices.
CPC H04L63/123, B62M6/75, G06F21/45Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$47.67m across 8 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
158 life sciences companies in New York work in oncology. Shown: the best-documented.
ImmunologyDeveloper of drugs for the treatment of cancer
ImmunotherapyDeveloper of treatments for B-cell malignancies and autoimmune diseases
OncologyProton Beam Therapy. Treatment for different types of Cancerous and non-cancerous tumors through Proton Therapy.
OncologyDeveloping novel immunotherapy agents for cancer and inflammatory diseases
OncologyDeveloper of small molecule therapeutics for cancer treatment
GenomicsDeveloper of small molecule therapeutics for cancer and genetic diseases
OncologyDeveloper of medical devices and biomarkers to detect various diseases
Cell therapyDeveloper of CAR-T cell therapy for brain cancer and acute myeloid leukemia treatment
GenomicsDeveloper of nanoparticle immunomodulatory drugs for treating multiple diseases
OncologyDeveloper of therapeutics for cancer treatment
OncologyDeveloper of therapeutics for the treatment of solid and liquid cancers
OncologyDeveloper of therapeutics for cancer
US$313.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in chemistry & materials
CPC C07H19/16, A61K31/5377, C07D487/14Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$115.61m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$54.93m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$124.40m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07D401/14, C07F9/65583, C12Q1/6886Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61B18/1492, A61M39/02, A61M25/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$95.00m across 2 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$155.09m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Tolerogenic nanocarrier delivery systems for immune‑tolerant therapeutic protein formulations
CPC A61K39/385, A61K31/436, A61K38/38Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Design and synthesis of heterocyclic small‑molecule cancer drugs targeting nuclear hormone receptors.
CPC C07D471/04, C07D487/04, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$128.15m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Cancer immunotherapy: GCN2 modulators, beta‑glucan/CD40 agonists, and novel crystalline drugs
CPC A61K31/716, A61K31/4985, C07D487/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
154 life sciences companies in New York work in genomics. Shown: the best-documented.
GenomicsProvider of next-generation gene-editing therapies

GenomicsProvider of COVID-19 testing platform

GenomicsDeveloper of next-generation of immunomodulatory therapeutics
GenomicsProvider of health management platform for employers and insurers
GenomicsDeveloper of small molecule therapeutics for cancer and genetic diseases
OncologyDeveloper of medical devices and biomarkers to detect various diseases
Life sciences platforms and toolsAccelerating drug discovery with precision preclinical services and innovative disease models
Life sciences platforms and toolsDiscovering novel therapeutics for neurological and metabolic diseases
GenomicsDeveloper of therapeutics for the treatment of rare neurological disorders
GenomicsDeveloper of nanoparticle immunomodulatory drugs for treating multiple diseases
Healthcare itLabcorp Oncology: Advancing cancer care through diagnostics, research, and precision medicine
GenomicsDeveloper of therapeutics for the treatment of orphan indications
US$3.75m across 2 disclosed equity rounds
Darker bars = larger rounds
Focus: Lipid nanoparticle delivery systems for tissue-specific CRISPR gene editing therapies.
CPC C12N15/11, C07D317/28, C12N15/1138Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.

Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$295.00m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$13.10m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$124.40m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C07D401/14, C07F9/65583, C12Q1/6886Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Patents concentrated in health & consumer products
CPC A61B18/1492, A61M39/02, A61M25/04Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: RNAi therapeutics: engineered amiRNA/miRNA design, regulation, and interferon decoy applications
CPC A01K67/0275, C12N15/1137, C12N15/113Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$479.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: NK3 receptor modulators for treating neurological and metabolic disorders
CPC C07D471/04, A61P1/00, C07D498/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$183.50m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: Engineered protein therapeutics for T‑reg activation and optimized GALC enzyme replacement.
CPC C07K16/2866, C07K14/475Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$155.09m across 9 disclosed equity rounds
Darker bars = larger roundsFocus: Tolerogenic nanocarrier delivery systems for immune‑tolerant therapeutic protein formulations
CPC A61K39/385, A61K31/436, A61K38/38Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$8.89m across 2 disclosed equity rounds
Darker bars = larger roundsFocus: AI-driven cancer genomics and biomarker analytics for personalized oncology therapies
CPC C12Q1/6886, G16B40/00, G16B10/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$127.74m across 3 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
132 life sciences companies in New York work in life sciences platforms and tools. Shown: the best-documented.
Life sciences platforms and toolsDeveloper of pipetting robot for lab automation
Life sciences platforms and toolsProvider of instruments for automated assays
Life sciences platforms and toolsAccelerating drug discovery with precision preclinical services and innovative disease models
Life sciences platforms and toolsDiscovering novel therapeutics for neurological and metabolic diseases
GenomicsDeveloper of live-attenuated viral vaccines using proprietary SAVE technology
Life sciences platforms and toolsAssisting life science research with noninvasive reporter genes, lentiviruses, cell lines, oncolytic viruses, and more.
GenomicsCloud platform for personal genomics
Materials techDeveloper of closed-loop positioning solutions
Life sciences platforms and tools3D Bio-printed living tissues
Life sciences platforms and toolsDeveloper of real-time color visualizing bleach-based disinfectant
Life sciences platforms and toolsParticle characterization solutions using Total Holographic Characterization for diverse applications
Life sciences platforms and toolsMedical device incubator creating innovative solutions for cardiology, pulmonary, and renal patients
US$260.68m across 6 disclosed equity rounds
Darker bars = larger roundsEach tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$72.72m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Patents concentrated in chemistry & materials
CPC C12Q1/6806, B81B1/00, F04B43/026Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: RNAi therapeutics: engineered amiRNA/miRNA design, regulation, and interferon decoy applications
CPC A01K67/0275, C12N15/1137, C12N15/113Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$479.00m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: NK3 receptor modulators for treating neurological and metabolic disorders
CPC C07D471/04, A61P1/00, C07D498/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$47.10m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Codon-deoptimized viral genome platforms for live-attenuated vaccines and immunotherapies
CPC A61K39/12, C07K14/08, C12N7/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$15.82m across 4 disclosed equity rounds
Darker bars = larger roundsFocus: Integrated low‑pass whole‑genome and targeted DNA sequencing for comprehensive genomic analysis
CPC C12Q1/6874Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Focus: Precision electromechanical actuation for optical beam steering and haptic devices
CPC H02N2/00, H02N2/02, H02N2/0095Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$32.27m across 5 disclosed equity rounds
Darker bars = larger roundsFocus: Antimicrobial surface decontamination formulations and stabilized colorant additives for cleaning products
CPC A61L2/28, C11D9/444, A47K10/421Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$1.78m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Advanced holographic imaging for particle characterization and cell viability assays
CPC G01N15/0227, G01N15/1459, G01N15/08Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
US$12.50m across 3 disclosed equity rounds
Darker bars = larger roundsFocus: Medical devices for cardiopulmonary therapy and steerable spine implant delivery systems
CPC A61B18/1492, A61F2/4611Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
332 more company lists you can search, plus the Radar directory pages for each place.
No list matches. Try a shorter word.
We will reply with coverage, fields and pricing for your use case.
Filed revenue, profit and growth for every company on this page are available with a Radar account. Log in and you will come straight back here with all figures open.